Press release
Atopic Dermatitis Drugs Market Analysis By Drug Type - Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants
Atopic Dermatitis Drugs Market
Atopic dermatitis is the type of eczema; patients who are suffering with this disease have super sensitive skin and a less threshold for irritation.
Atopic dermatitis consists of hay fever, allergic asthma, atopic dermatitis, food allergies and anaphylaxis.
The rapid development of novel pipeline drugs is expected to accelerate the market growth in the forecast period.
Likewise, the rise in demand for new biologics and product approvals are also predictable to enhance the atopic dermatitis market growth.
Furthermore, the favourable reimbursement policies in emerging countries and high prevalence of atopic dermatitis are also projected to drive the market growth rate.
Also, the increase in awareness regarding the availability of treatments for the disease and various initiatives undertaken by governments to provide better and more affordable treatment are also expected to influence the atopic dermatitis market growth globally.
Click Here To Access The Free Sample Report @ https://analyticsmarketresearch.com/sample-request/atopic-dermatitis-drugs-market/27488/
Global Atopic Dermatitis Market: Overview
The Global Atopic Dermatitis Market is valued at US $5.65 Billion in 2022 is anticipated to reach a value of US $8.60 Billion in 2030, growing at a CAGR of 5.4%.
Dermatological disorders are highly prevalent in various forms across the globe. According to the World Health Organization, more than 900 million people were affected by skin diseases.
Out of these diseases, atopic dermatitis affects more than 300 million people globally.
Around one-fifth of the victims include children. This increased incidence of this disease is expected to leverage the growth of the atopic dermatitis market in the foreseeable future.
Other factors, such as the development of novel pipeline drugs and rising demand for new biologics and product approvals, are also expected to augment atopic dermatitis drugs demand.
Key Trends of Global Atopic Dermatitis Market:
Corticosteroids Remain the Drug of Choice
Corticosteroids are referred as the first choice of treatment for the inflammation and pain relief. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling and redness. Around 30 corticosteroid compounds have been licensed for atopic dermatitis treatment, of which ‘hydrocortisone’ is considered as the first. In addition, increasing innovations have resulted in the advent of topical non-corticosteroids immunomodulators and target medications, for example, immunomodulators such as pimecrolimus and tacrolimus, which in turn, is likely to fuel the growth of the atopic dermatitis treatment market. Moreover, topical corticosteroids are expected to play an important role in the atopic dermatitis treatment.
Rise in awareness regarding the availability of treatments for the disease
Initiatives undertaken by governments to provide better and more affordable treatment and the presence of favorable reimbursement policies are likely to provide an upthrust to the market. Furthermore, growing acceptance of targeted therapies such as Eucrisa and Dupixent is also working in favor of the market.
High cost of therapeutics is one of the key roadblocks in the upward climb of the market. However, affordable healthcare measures are being incorporated across all major regions, impacting pricing strategies of companies as well as reimbursement scenarios.
Segmental Analysis of Global Atopic Dermatitis Market:
Based on Drug Class
• Corticosteriods
• Calcenriun Inhibitors
• PDE4 Inhibitors
• Biologic
• Others
Corticosteroids have been the mainstay for AD treatment. Being the first-line therapy, this drug class is projected to maintain sizeable share in the market through 2022. Corticosteroids accounted for about 45.0% share in the market. Calcineurin inhibitors are proven to increase the chances of nephrotoxicity and carcinogenesis. Non-specificity, toxic effects, and development of resistance to this therapeutic class are poised to stifle the growth of the segment and encourage switching to other targeted therapies.
Based on Route of Administration
• Oral
• Injectable
• Tropical
Topical products led the market and represented 70.0% of the market. Topical corticosteroids are the most widely prescribed medications for AD. They are often administered in combination with moisturizers or emollients for more effective results.
Based on Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Purchase This Premium Report Now @ https://analyticsmarketresearch.com/purchase/atopic-dermatitis-drugs-market/27488/?license=single
Geographical Analysis of Global Atopic Dermatitis Market:
The Global Atopic Dermatitis Market is further segmented into five major countries- North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
The U.S. market is anticipated to register a healthy CAGR during the forecast period. Increasing incidence of atopic dermatitis, soaring treatment rate, and inflated drug prices are some of the key trends augmenting revenue generation in the country.
Increased awareness about atopic dermatitis, favourable medical reimbursement policies and well-established healthcare facilities are projected to leverage Europe’s market share.
Competitive Landscape:
Abbvie INC., Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, Teva Pharmaceutical Industries Ltd., Novaritis AG, Sanofi S.A, GlaxoSmithKline PLC.
Scope of the Report:
Global Atopic Dermatitis Market: Historical Year- 2018-2021
Global Atopic Dermatitis Market: Forecast Year- 2022-2030
Global Atopic Dermatitis Market USD value in 2022- US $5.65 Billion
Global Atopic Dermatitis Market USD value in 2030- US $8.60 Billion
Global Atopic Dermatitis Market CAGR- 5.4%
Segments covered- Route of Administration, Distribution channel, Drug Class and Region
Region Covered-
• North America (US, Canada, Mexico)
• Europe (Spain, Italy, UK, Germany, France, Russia)
• Asia-Pacific (India, China, Japan, Australia, South Korea)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (UAE, Saudi Arabia, South Africa)
Key Players: Abbvie INC., Bausch Health Companies Inc., Bayer AG, Bristol-Myers Squibb Company, Pfizer, Eli Lilly, Teva Pharmaceutical Industries Ltd., Novaritis AG, Sanofi S.A, GlaxoSmithKline PLC.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Read Full Research Report @ https://analyticsmarketresearch.com/reports/atopic-dermatitis-drugs-market/27488/
Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Website: https://analyticsmarketresearch.com/contactus/
About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Drugs Market Analysis By Drug Type - Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants here
News-ID: 2898892 • Views: …
More Releases from Analytics Market Research
Global Texture Paint Market Rising Trends, Technology Research and Advancement O …
The Global Texture Paint Market size was valued at USD 12,400 million in 2022 and is projected to reach USD 16,700 million by 2033, growing at a CAGR of 4.5% during the forecast period.
The texture paint market refers to the industry involved in the production, distribution, and sale of texture paints. Texture paints are specialized coatings used to add texture and visual interest to surfaces, such as walls, ceilings, furniture,…
Guarding the Global Flow: Exploring the Growth Potential and Security Innovation …
The global Supply Chain Security Market size was valued at USD 2.56 billion in 2022, and is projected to reach USD 3.57 billion by 2032 at a CAGR of 11.5% from 2023 to 2032.
The supply chain security market refers to the set of solutions and services aimed at securing the flow of goods, services, and information across the global supply chain. The primary objective of supply chain security is to…
Clouding the Future: Unveiling the Global Public Cloud Market's Transformation a …
The global public cloud market was estimated at USD 211.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2032. Rapid progress of digital transformation in the industry, prevalence of internet and mobile devices, and increasing consumption of big data are the major drivers of market growth.
Developing next-generation industrial solutions is leveraging the cloud and requires a platform that…
Revolutionizing Education: Exploring the Global Learning Management System Marke …
The global Learning Management System Market size was valued at USD 27.56 billion in 2022, and is projected to reach USD 62.57 billion by 2032 at a CAGR of 18.5% from 2023 to 2032.
A Learning Management System (LMS) is a software application designed to manage and deliver educational and training courses, resources, and assessments to learners. It is used by educational institutions, businesses, and organizations to create and deliver courses,…
More Releases for Atopic
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
